In 2009, news that a single surgery ( Trigger- point release/nerve decompression ) can improve migraines and chronic headaches spread worldwide. Subsequently in October 2010, the FDA approved BOTOX® (Allergan, Inc) for chronic migraines . Drugs prescribed for migraines and chronic headaches may not help sufferers. Moreover, they have adverse effects, including mental sluggishness, nausea, muscle weakness, difficulty in thinking, and trouble functioning.
Through trigger-point release, the pressure on nervesarerelieved, thus preventing migraines and persistent headaches, or decreasing the frequency and intensity of pain. Reports have found that nearly 80% to 90% of patients experience improvement in pain and, in 50% to 60% of patients, the headaches are completely eliminated.